Copyright: ©Author(s) 2026.
World J Hepatol. Apr 27, 2026; 18(4): 114861
Published online Apr 27, 2026. doi: 10.4254/wjh.v18.i4.114861
Published online Apr 27, 2026. doi: 10.4254/wjh.v18.i4.114861
Table 1 Comparison of existing prognostic models in acute-on-chronic liver failure and alpha-fetoprotein dynamics
| Prognostic tool | Main inputs | Strengths | Limitations | Reflects regenerative potential |
| CTP score | Hepatic encephalopathy, ascites, total bilirubin, albumin, prothrombin time | Simple | Subjective, grading stenosis and lack of corresponding weights for each indicator | Low |
| MELD score | Bilirubin, INR, creatinine | Widely validated; useful for transplant allocation; objective indicators; reliable indicators; easy to obtain | Some clinical factors are not taken into account | Low |
| SOFA | Six organ systems: Respiration; coagulation; liver; cardiovascular; renal, CNS | Simple; continuous monitoring; widely used in ICU | Primarily reflects organ injury, not liver regeneration | Low |
| COSSH-ACLF score | Bilirubin, INR, creatinine, neutrophil count, organ failures | Developed from HBV-ACLF cohort; good regional fit | Limited generalizability; retrospective | Low-moderate |
| CLIF-C ACLF score | Bilirubin, creatinine, INR, organ failures | Tailored for ACLF; good short-term | Requires multiple parameters; complex | Low-moderate |
| AARC score | Bilirubin, INR, lactate, creatinine, encephalopathy | Useful in Asian cohorts; emphasizes metabolic stress | Limited global validation; static | Low-moderate |
| AFP dynamics | Baseline AFP + serial change | Inexpensive; widely available; reflects regeneration | Confounded by etiology, necrosis, malignancy; not yet standardized | High |
- Citation: Niu XX, Yang XJ. Letter to the Editor: Serum alpha-fetoprotein dynamics in liver failure - prognostic implications and clinical insights. World J Hepatol 2026; 18(4): 114861
- URL: https://www.wjgnet.com/1948-5182/full/v18/i4/114861.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i4.114861
